APA (7th ed.) Citation

YT, Y., SC, L., CN, H., YS, Y., PL, L., & E, K. (2025). Comparative cardiovascular outcomes of aripiprazole vs. risperidone in patients with type 2 diabetes and schizophrenia: A retrospective cohort study. Frontiers in pharmacology, 16, 1617534. https://doi.org/10.3389/fphar.2025.1617534

Chicago Style (17th ed.) Citation

YT, Yeh, Lo SC, Huang CN, Yang YS, Liao PL, and Kornelius E. "Comparative Cardiovascular Outcomes of Aripiprazole Vs. Risperidone in Patients with Type 2 Diabetes and Schizophrenia: A Retrospective Cohort Study." Frontiers in Pharmacology 16 (2025): 1617534. https://doi.org/10.3389/fphar.2025.1617534.

MLA (9th ed.) Citation

YT, Yeh, et al. "Comparative Cardiovascular Outcomes of Aripiprazole Vs. Risperidone in Patients with Type 2 Diabetes and Schizophrenia: A Retrospective Cohort Study." Frontiers in Pharmacology, vol. 16, 2025, p. 1617534, https://doi.org/10.3389/fphar.2025.1617534.